Two Sigma Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-272,300
| Closed | -$14.3M | – | 2704 |
|
|
2020
Q3 | $14.3M | Sell |
272,300
-91,400
| -25% | -$3.78M | 0.04% | 419 |
|
|
2020
Q2 | $12.1M | Buy |
363,700
+11,300
| +3% | +$360K | 0.04% | 482 |
|
|
2020
Q1 | $9.59M | Buy |
352,400
+86,000
| +32% | +$2.39M | 0.04% | 493 |
|
|
2019
Q4 | $5.26M | Buy |
266,400
+162,600
| +157% | +$2.6M | 0.01% | 828 |
|
|
2019
Q3 | $1.34M | Sell |
103,800
-32,400
| -24% | -$391K | ﹤0.01% | 1305 |
|
|
2019
Q2 | $1.7M | Sell |
136,200
-18,990
| -12% | -$252K | ﹤0.01% | 1284 |
|
|
2019
Q1 | $2.25M | Sell |
155,190
-5,700
| -4% | -$72.8K | 0.01% | 1165 |
|
|
2018
Q4 | $1.78M | Buy |
160,890
+18,990
| +13% | +$264K | ﹤0.01% | 1223 |
|
|
2018
Q3 | $3.73M | Sell |
141,900
-3,800
| -3% | -$103K | 0.01% | 942 |
|
|
2018
Q2 | $2.98M | Sell |
145,700
-4,300
| -3% | -$92.3K | 0.01% | 1107 |
|
|
2018
Q1 | $2.72M | Buy |
150,000
+200
| +0.1% | +$3.33K | 0.01% | 1100 |
|
|
2017
Q4 | $2.09M | Buy |
149,800
+16,510
| +12% | +$223K | 0.01% | 1222 |
|
|
2017
Q3 | $2.47M | Buy |
133,290
+30,100
| +29% | +$503K | 0.01% | 1106 |
|
|
2017
Q2 | $1.74M | Sell |
103,190
-29,900
| -22% | -$455K | 0.01% | 1268 |
|
|
2017
Q1 | $1.78M | Sell |
133,090
-6,400
| -5% | -$100K | 0.01% | 1310 |
|
|
2016
Q4 | $2.1M | Buy |
139,490
+700
| +0.5% | +$9.24K | 0.01% | 1152 |
|
|
2016
Q3 | $1.62M | Sell |
138,790
-89,200
| -39% | -$1.05M | 0.01% | 1123 |
|
|
2016
Q2 | $2.46M | Sell |
227,990
-6,000
| -3% | -$61.9K | 0.01% | 788 |
|
|
2016
Q1 | $2.16M | Sell |
233,990
-56,400
| -19% | -$607K | 0.01% | 777 |
|
|
2015
Q4 | $4.31M | Buy |
290,390
+19,200
| +7% | +$321K | 0.03% | 491 |
|
|
2015
Q3 | $4.49M | Buy |
271,190
+40,700
| +18% | +$833K | 0.03% | 498 |
|
|
2015
Q2 | $5.26M | Buy |
230,490
+108,600
| +89% | +$2.16M | 0.04% | 463 |
|
|
2015
Q1 | $1.85M | Buy |
121,890
+73,000
| +149% | +$948K | 0.01% | 807 |
|
|
2014
Q4 | $589K | Buy |
48,890
+26,900
| +122% | +$307K | ﹤0.01% | 1498 |
|
|
2014
Q3 | $249K | Buy |
+21,990
| New | +$251K | ﹤0.01% | 2003 |
|
|
2013
Q3 | – | Sell |
-29,590
| Closed | -$445K | – | 2498 |
|
|
2013
Q2 | $445K | Buy |
+29,590
| New | +$391K | 0.01% | 1409 |
|
Two Sigma Advisers's MNTA Position: Q4 2020 in Review
Two Sigma Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 272,300 shares — an estimated $14.3M sold.
Two Sigma Advisers first reported a position in MNTA in Q2 2013 and held it in 26 quarters. The position peaked at $14.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Two Sigma Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Two Sigma Advisers sold 272,300 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $14.3M.
- Two Sigma Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
- Two Sigma Advisers's Momenta Pharmaceuticals, Inc. position peaked at $14.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.